Skip to main content

Table 2 Medication outcome with Metformin use.

From: Clinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia

Parameters (N = 501) Metformin N(%)  
  Monotherapy Combination χ 2 value
Monitoring    
   Fasting Plasma glucose 105 (20.9) 396 (79.1) 0.001
Controlled 44 (41.9) 92 (23.2)  
Uncontrolled 61 (58.1) 304 (76.8)  
Adverse Effects    
   Nausea - 1 (0.3)  
   Bloating - 4 (1.0)  
   Diarrhea 1 (0.9) 3 (0.8)  
   Headache - 1 (0.3)  
   Weakness - 4 (1.0)  
No adverse effects 104 (99.1) 383 (96.6) 0.023
Hypertension complication    
   YES 86 (81.9) 303 (76.5) 0.001
   NO 19 (18.1) 93 (23.5)